メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

EpiCast Report:急性冠症候群 (ACS) の疫学予測

EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025

発行 GlobalData 商品コード 293249
出版日 ページ情報 英文 79 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.76円で換算しております。
Back to Top
EpiCast Report:急性冠症候群 (ACS) の疫学予測 EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025
出版日: 2016年08月08日 ページ情報: 英文 79 Pages
概要

世界の主要7ヶ国 (米国、フランス、ドイツ、イタリア、スペイン、英国、日本) における急性冠症候群 (ACS) と診断された患者数は、2015年の2,545万人から、2025年には3,062万人まで増加する (年間平均増加率2.03%) と予測されています。

当レポートでは、世界の主要7ヶ国における急性冠症候群 (ACS) について調査分析し、疾患の背景、危険因子と併存疾患、世界の動向、疫学予測などについて、体系的な情報を提供しています。

第1章 目次

第2章 疫学

  • 疾患の背景
  • 危険因子と併存疾患
  • 世界の動向
  • 予測手法
    • 利用した情報源
    • 予測の前提条件と手法
    • 利用しなかった情報源
  • ACSの疫学予測
    • ACSと診断された患者数
    • ACSと診断された患者数 (年齢別)
    • ACSと診断された患者数 (性別)
    • ACSと診断された患者数:STEMI、NSTEMI、UA別
    • ACSと診断された患者数 (年齢調整)
    • ACSの入院期間
    • ACSの入院期間 (性別)
    • ACSの入院期間:STEMI、NSTEMI、UA別
  • 議論
    • 疫学予測の考察
    • 分析の限界
    • 分析の強み

第3章 付録

図表

目次
Product Code: GDHCER124-16

Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ACS incidence increases with age and will be a significant public health problem as the elderly population increases around the world.

ACS is an umbrella term that describes conditions in which blood flow to the heart is blocked or reduced due to atherosclerotic plaques composed of white blood cells, cholesterol, and fat. ACS is classified into three disease entities based on evidence of heart muscle damage inferred from a person's symptoms, changes in the ST tracing of the electrocardiogram (ECG), and levels of cardiac biomarkers that signify heart muscle death.

Epidemiologists forecast that in the 7MM, the diagnosed prevalent cases of ACS will grow from 25.45 Million cases in 2015 to 30.62 Million cases in 2025, at an Annual Growth Rate (AGR) of 2.03%. Throughout the forecast period, the diagnosed prevalent cases of ACS in the US will constitute the highest proportion in the 7MM at approximately 54%.

In the 7MM, the diagnosed prevalent cases of ACS will be higher in men (61.81%) and in the age group older than 65 years (62.84%). STEMI, NSTEMI, and UA will constitute approximately 25%, 40%, and 35% of the diagnosed prevalent cases of ACS in the 7MM.

In the 7MM, epidemiologists project ACS hospitalizations to increase from 1.63 Million cases in 2015 to 1.71 Million cases in 2025 at an AGR of 0.51%. The US constitutes around 40% of the total hospitalized ACS cases in the 7MM for the year 2015 and will be the market with the highest number of cases during the forecast period. In 2015, the majority of the ACS hospitalizations occurred in men (62.85%) and in the age group older than 65 years (69.34%).

The report “EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025” provides an overview of the risk factors, comorbidities, and the global and historical trends for ACS in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast from 2015-2025 for the diagnosed prevalent cases of ACS, segmented by sex, age (in 10 year age groups from ages =25 years), and ACS type (STEMI, NSTEMI, and UA), and a 10-year epidemiological forecast for ACS hospitalizations, segmented by sex and ACS type (STEMI, NSTEMI, and UA).

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Epidemiology

  • 2.1. Disease Background
  • 2.2. Risk Factors and Comorbidities
  • 2.3. Global Trends
    • 2.3.1. ACS Diagnosed Prevalence
    • 2.3.2. STEMI and NSTEMI Trends
    • 2.3.3. ACS Hospitalizations
  • 2.4. Forecast Methodology
    • 2.4.1. Sources Used
    • 2.4.2. Forecast Assumptions and Methods
    • 2.4.3. Sources Not Used
  • 2.5. Epidemiological Forecast for ACS (2015-2025)
    • 2.5.1. Diagnosed Prevalent Cases of ACS
    • 2.5.2. Age-Specific Diagnosed Prevalent Cases of ACS
    • 2.5.3. Sex-Specific Diagnosed Prevalent Cases of ACS
    • 2.5.4. Diagnosed Prevalent Cases of ACS Segmented by STEMI, NSTEMI, and UA
    • 2.5.5. Age-Standardized Diagnosed Prevalence of ACS
    • 2.5.6. ACS Hospitalizations
    • 2.5.7. Sex-Specific ACS Hospitalizations
    • 2.5.8. ACS Hospitalizations Segmented by STEMI, NSTEMI, and UA
  • 2.6. Discussion
    • 2.6.1. Epidemiological Forecast Insight
    • 2.6.2. Limitations of the Analysis
    • 2.6.3. Strengths of the Analysis

3. Appendix

  • 3.1. Bibliography
  • 3.2. About the Authors
    • 3.2.1. Epidemiologists
    • 3.2.2. Reviewers
    • 3.2.3. Global Director of Therapy Analysis and Epidemiology
    • 3.2.4. Global Head of Healthcare
  • 3.3. About GlobalData
  • 3.4. About EpiCast
  • 3.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for ACS
  • Table 2: Global, Crude Total Population Prevalence Percentages of Angina Pectoris and Mean Age of Study Participants
  • Table 3: 7MM, Sources of Diagnosed Prevalence Data for MI
  • Table 4: 7MM, Data Sources of STEMI and NSTEMI Proportions Among Diagnosed Prevalent Cases of MI
  • Table 5: 7MM, Data Sources of ACS Hospitalizations
  • Table 6: 7MM, Data Sources of STEMI and NSTEMI Proportions Among MI Hospitalizations
  • Table 7: 7MM, Diagnosed Prevalent Cases of ACS, Ages ≥25 Years, Both Sexes, N, Select Years, 2015-2025
  • Table 8: 7MM, Age-Specific Diagnosed Prevalent Cases of ACS, Men and Women, N (Row %), 2015
  • Table 9: 7MM, Sex-Specific Diagnosed Prevalent Cases of ACS, Ages ≥25 Years, N (Row %), 2015
  • Table 10: 7MM, Diagnosed Prevalent Cases of STEMI, NSTEMI, and UA, Ages ≥25 Years, N (Row %), 2015
  • Table 11: 7MM ACS Hospitalizations, Ages ≥25 Years, Both Sexes, N, Select Years, 2015-2025
  • Table 12: 7MM, Sex-Specific ACS Hospitalizations, Ages ≥25 Years, N (Row %), 2015
  • Table 13: 7MM, Diagnosed ACS Hospitalizations Segmented by STEMI, NSTEMI and UA, Ages ≥25 Years, Both Sexes, N, 2015

List of Figures

  • Figure 1: US, Germany, and UK, Crude Diagnosed MI Prevalence in Men and Women, 1990-2008
  • Figure 2: Global, Crude Total Population Prevalence Percentages of Angina Pectoris (%)
  • Figure 3: Case Segmentation Map
  • Figure 4: 7MM, Diagnosed Prevalent Cases of ACS, Ages ≥25 Years, Both Sexes, N, Select Years, 2015-2025
  • Figure 5; 7MM, Age-Specific Diagnosed Prevalent Cases of ACS, Men and Women, N, 2015
  • Figure 6: 7MM, Sex-Specific Diagnosed Prevalent Cases of ACS, Ages ≥25 Years, N, 2015
  • Figure 7: 7MM, Diagnosed Prevalent Cases of STEMI and NSTEMI, Ages ≥25 Years, N, 2015
  • Figure 8: 7MM, Age-Standardized Diagnosed Prevalence of ACS, Ages ≥25 Years, 2015
  • Figure 9: 7MM ACS Hospitalizations, Ages ≥25 Years, Both Sexes, N, Select Years, 2015-2025
  • Figure 10: 7MM, Sex-Specific ACS, Ages ≥25 Years, N, 2015
  • Figure 11: 7MM, Diagnosed ACS Hospitalizations Segmented by NSTEMI and STEMI, Ages ≥25 Years, Both Sexes, N, 2015
Back to Top